Gbm-12401

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameGbm-12401

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionTopoisomerase II inhibitorsReceptor protein-tyrosine kinase erbB-2 modulators

TargetsTopoisomerase IIReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGreat Novel Therapeutics Biotech & Medicals Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGreat Novel Therapeutics Biotech & Medicals Corp

Active IndicationsN/A

Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A